SCHEMBL2945448

SCHEMBL2945448

CCn1c2ccc(C(C)=O)cc2c2cc(C(=O)c3ccc(N4CCOCC4)cc3)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.52
KDM4E B2RXH2 7/20 0.52
ALDH1A1 P00352 7/20 0.52
KMT2A Q03164 6/20 0.52
MEN1 O00255 5/20 0.52
MAPK1 P28482 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
HPGD P15428 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
NPY5R Q15761 2/20 0.47
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ATM Q13315 1/20 0.47
TUBB4A P04350 1/20 0.45
TUBB P07437 1/20 0.45
TUBA3C P0DPH7 1/20 0.45
TUBA1B P68363 1/20 0.45
TUBA4A P68366 1/20 0.45
TUBB4B P68371 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2955229 0.89 KDM4E (0.62) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL2955232 0.89 KDM4E (0.62) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL14549133 0.89 MAPT (0.49) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL10098916 0.85 MAPT (0.46) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL2735111 0.85 KDM4E (0.58) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL30163436 0.80 CNR2 (0.61) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL13674479 0.80 CNR2 (0.61) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL13236634 0.80 KDM4E (0.52) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL31680366 0.80 KDM4E (0.55) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL14982088 0.79 MAPT (0.68) MAPTKDM4EALDH1A1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759043-B2 Oxime ester photoinitiators CIBA SPECIALTY CHEMICALS CORP. (US) 2010-07-20 US disclosed
US-20080096115-A1 Oxime Ester Photoinitiators CIBA SPECIALTY CHEMICALS CORP. 2008-04-24 US disclosed
EP-1778636-B1 OXIME ESTER PHOTOINITIATORS CIBA SC HOLDING AG (CH) 2007-12-19 EP disclosed
EP-1778636-A1 OXIME ESTER PHOTOINITIATORS Ciba SC Holding AG (CH) 2007-05-02 EP disclosed
WO-2006018405-A1 OXIME ESTER PHOTOINITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096115-A1 Oxime Ester Photoinitiators NR2E3, CBR3, AHR MAPT 4688/4885KDM4E 989/4885ALDH1A1 1321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.